Related Experiment Video
Updated: Aug 18, 2026

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
Regulatory affairs as they affect invasive cardiology
1IsoStent, Inc., 14600 Viburnum Drive, Dayton, Maryland 21036, USA.
Abstract:
Over the last several years, the United States Food and Drug Administration (FDA) has significantly improved the time required for the approval of PMA and PMA supplement applications. By the year 1999, the average approval time for PMA applications was 12 months and the average approval time for PMA supplements was only 4 months. In spite of this improved performance by the FDA, it is still advantageous for many products to have their first clinical trial outside the United States.
More Related Videos
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization III: Left Heart Catheterization
Cardiac Catheterization IV: Nursing Management
Aortic Regurgitation III: Medical Management
Aortic Regurgitation IV: Nursing Management
Cardiomyopathy V: Interprofessional Care

